Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.
Chunrong TaoRaul G NogueiraYuyou ZhuJun SunHongxing HanGuangxiong YuanChangming WenPeiyang ZhouWenhuo ChenGuoyong ZengYuwen LiZhengfei MaChuanqing YuJunfeng SuZhiming ZhouZhongjun ChenGeng LiaoYaxuan SunYouquan RenHui ZhangJie ChenXincan YueGuodong XiaoLi WangRui LiuWenhua LiuYong LiuLi WangChao ZhangTianlong LiuJianlong SongRui LiPengfei XuYamei YinGuoping WangBlaise BaxterAdnan I QureshiXinfeng LiuWei Hunull nullPublished in: The New England journal of medicine (2022)
In a trial involving Chinese patients with basilar-artery occlusion, approximately one third of whom received intravenous thrombolysis, endovascular thrombectomy within 12 hours after stroke onset led to better functional outcomes at 90 days than best medical care but was associated with procedural complications and intracerebral hemorrhage. (Funded by the Program for Innovative Research Team of the First Affiliated Hospital of USTC and others; ATTENTION ClinicalTrials.gov number, NCT04751708.).
Keyphrases
- endovascular treatment
- phase iii
- study protocol
- acute ischemic stroke
- phase ii
- clinical trial
- quality improvement
- aortic dissection
- liver failure
- pulmonary embolism
- brain injury
- healthcare
- working memory
- high dose
- respiratory failure
- palliative care
- randomized controlled trial
- risk factors
- open label
- low dose
- adverse drug
- intensive care unit
- extracorporeal membrane oxygenation
- mechanical ventilation